FDA: Policy Allows for Expanded Use of Certain Remote Patient Monitoring Devices
The policy is intended to remain in effect only for the duration of the COVID-19 public health emergency declared by the Department of Health and Human Services (HHS).
Diagnosis & Disease Information
Update on REMS-Required Testing During COVID-19 Pandemic
For patients suspected of having COVID-19, undergoing REMS-required testing to obtain a medication may put others at risk.
ACAAI: Albuterol Inhalers May Be in Short Supply Due to COVID-19
The American College of Allergy, Asthma and Immunology announced a growing shortage of albuterol inhalers in certain areas throughout the US during the COVID-19 pandemic.
Serial Interval of COVID-19 Estimated at 3.96 Days
Reports show infectee can develop symptoms before infector, indicating presymptomatic transmission.
Lopinavir-Ritonavir Does Not Offer Substantial Benefit in Severe COVID-19
In patients who were hospitalized with severe coronavirus disease, treatment with lopinavir-ritonavir did not provide a substantial benefit beyond standard care.
FDA: Studies Underway to Evaluate Chloroquine for COVID-19
The FDA announced that it is working closely with other government agencies and academic centers to investigate the potential use of chloroquine for the treatment of coronavirus disease 2019 (COVID-19).
FDA Issues Statement Regarding NSAID Use and COVID-19
The FDA has issued a statement regarding the use of nonsteroidal anti-inflammatory drugs (NSAIDS) in patients with coronavirus disease 2019 (COVID-19).
COVID-19 Preparedness for Radiology Departments Outlined
Preparedness includes early detection and limiting exposure of health care workers, hospital employees
MPR Weekly Dose Podcast Episode 26
This week we talk about a phase 1 trial for a potential COVID-19 vaccine that is underway in Seattle; Concerns over COVID-19 and ACE inhibitor, ARB use; Safety labeling changes for SGLT2 inhibitors; A biosimilar to Herceptin; And new graphic warnings for cigarette packages.
Supply Shortages Hinder COVID-19 Testing in the United States
Face mask shortage prompting the CDC to suggest the use of bandannas, if necessary.
